Suppr超能文献

与多囊卵巢综合征相关的常见内分泌疾病。

Common endocrine disorders associated with the polycystic ovary syndrome.

作者信息

Abdelazim Ibrahim A, Amer Osama O, Farghali Mohamed

机构信息

Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt.

Department of Obstetrics and Gynecology, Ahmadi Hospital, Kuwait Oil Company, Ahmadi, Kuwait.

出版信息

Prz Menopauzalny. 2020 Dec;19(4):179-183. doi: 10.5114/pm.2020.101948. Epub 2021 Jan 7.

Abstract

INTRODUCTION

Screening of polycystic ovary syndrome (PCOS) women for hypothyroidism and hyperprolactinemia was suggested, because the undiagnosed hypothyroidism and hyperprolactinemia can aggravate the PCOS symptoms.

AIM OF THE STUDY

To determine whether the insulin resistance (IR), hypothyroidism, and hyperprolactinemia are common endocrine disorders associated with the PCOS.

MATERIAL AND METHODS

One hundred and twenty PCOS women were compared to 120 non-PCOS controls in this study. Participants' day 2-3 hormonal profile and insulin resistance (IR) using the fasting glucose and fasting insulin were evaluated. Collected data were analyzed to determine whether the IR, hypothyroidism, and hyperprolactinemia are common endocrine disorders associated with the PCOS.

RESULTS

TSH and prolactin were significantly high in PCOS women (6.4 ±4.2 and 934 ±102.3, respectively) than controls (3.5 ±3.3 and 445 ±77.5 mIU/ml, respectively) ( = 0.004 and 0.001, respectively). The PCOS women had significantly high relative risk of IR (RR 3.0 (95% CI: 1.9-4.7) < 0.0001), hypothyroidism (RR 3.4; 95% CI: 1.7-6.9) ( = 0.0005), and hyperprolactinaemia (RR 3.15; 95% CI: 1.8-5.6) ( = 0.0001) than controls. The PCOS women had higher odds of IR (OR 4.8; 95% CI: 2.6-8.8) ( < 0.0001), hypothyroidism (OR 4.29; 95% CI: 1.9-9.4) ( = 0.0003), and hyperprolactinaemia (OR 4.27; 95% CI: 2.1-8.5) ( < 0.0001) than controls.

CONCLUSIONS

TSH and prolactin were significantly high in studied PCOS women, and 47.5% of the studied PCOS women had IR. The PCOS women had significantly higher odds and relative risks of IR, hypothyroidism, and hyperprolactinemia than controls. IR, hypothyroidism, and hyperprolactinemia are common endocrine disorders associated with PCOS.

摘要

引言

建议对多囊卵巢综合征(PCOS)女性进行甲状腺功能减退和高泌乳素血症筛查,因为未诊断出的甲状腺功能减退和高泌乳素血症会加重PCOS症状。

研究目的

确定胰岛素抵抗(IR)、甲状腺功能减退和高泌乳素血症是否为与PCOS相关的常见内分泌疾病。

材料与方法

本研究将120例PCOS女性与120例非PCOS对照进行比较。评估参与者第2 - 3天的激素水平以及使用空腹血糖和空腹胰岛素评估胰岛素抵抗(IR)。对收集的数据进行分析,以确定IR、甲状腺功能减退和高泌乳素血症是否为与PCOS相关的常见内分泌疾病。

结果

PCOS女性的促甲状腺激素(TSH)和泌乳素水平显著高于对照组(分别为6.4±4.2和934±102.3,而对照组分别为3.5±3.3和445±77.5 mIU/ml)(P值分别为0.004和0.001)。PCOS女性发生IR的相对风险显著较高(RR 3.0(95%CI:1.9 - 4.7),P<0.0001)、甲状腺功能减退(RR 3.4;95%CI:1.7 - 6.9)(P = 0.0005)以及高泌乳素血症(RR 3.15;95%CI:1.8 - 5.6)(P = 0.0001)。与对照组相比,PCOS女性发生IR的几率更高(OR 4.8;95%CI:2.6 - 8.8)(P<0.0001)、甲状腺功能减退(OR 4.29;95%CI:1.9 - 9.4)(P = 0.0003)以及高泌乳素血症(OR 4.27;95%CI:2.1 - 8.5)(P<0.0001)。

结论

在研究的PCOS女性中,TSH和泌乳素水平显著升高,且47.5%的研究对象患有IR。与对照组相比,PCOS女性发生IR、甲状腺功能减退和高泌乳素血症的几率及相对风险显著更高。IR、甲状腺功能减退和高泌乳素血症是与PCOS相关的常见内分泌疾病。

相似文献

1
Common endocrine disorders associated with the polycystic ovary syndrome.
Prz Menopauzalny. 2020 Dec;19(4):179-183. doi: 10.5114/pm.2020.101948. Epub 2021 Jan 7.
2
The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS.
Front Endocrinol (Lausanne). 2023 Oct 3;14:1245106. doi: 10.3389/fendo.2023.1245106. eCollection 2023.
3
Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
Int J Fertil Steril. 2016 Apr-Jun;10(1):22-8. doi: 10.22074/ijfs.2016.4764. Epub 2016 Apr 5.
4
Thyroid-stimulating Hormone and Insulin Resistance: Their Association with Polycystic Ovary Syndrome without Overt Hypothyroidism.
Rev Bras Ginecol Obstet. 2017 May;39(5):224-228. doi: 10.1055/s-0037-1601436. Epub 2017 Apr 11.
5
Abdelazim and Sakiyeva endocrinopathy associated with polycystic ovary syndrome: Case reports.
J Family Med Prim Care. 2019 Sep 30;8(9):3039-3041. doi: 10.4103/jfmpc.jfmpc_646_19. eCollection 2019 Sep.
6
Correlation of Subclinical Hypothyroidism With Polycystic Ovary Syndrome (PCOS).
Cureus. 2020 May 15;12(5):e8142. doi: 10.7759/cureus.8142.
10
[Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Aug 28;42(8):940-946. doi: 10.11817/j.issn.1672-7347.2017.08.011.

引用本文的文献

1
The relationship between vitamin D and adolescents' parathyroid hormone and bone mineral density.
Prz Menopauzalny. 2024 Mar;23(1):1-5. doi: 10.5114/pm.2024.136327. Epub 2024 Mar 17.
2
The effect of vitamin D on adolescents' primary dysmenorrhea.
J Med Life. 2023 Nov;16(11):1658-1662. doi: 10.25122/jml-2023-0290.
3
The impact of primary dysmenorrhea on adolescents' activities and school attendance.
J Med Life. 2023 Oct;16(10):1462-1467. doi: 10.25122/jml-2023-0247.
4
Relationship between vitamin D and adolescents' hypothyroidism - a cross-sectional study.
Prz Menopauzalny. 2023 Dec;22(4):186-190. doi: 10.5114/pm.2023.133280. Epub 2023 Nov 29.
6
Relation between vitamin D and adolescents' serum prolactin.
Prz Menopauzalny. 2023 Dec;22(4):202-206. doi: 10.5114/pm.2023.133883. Epub 2023 Dec 21.
7
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects.
Life (Basel). 2023 Oct 26;13(11):2124. doi: 10.3390/life13112124.
8
The relation between primary dysmenorrhea in adolescents and body mass index.
Prz Menopauzalny. 2023 Sep;22(3):126-129. doi: 10.5114/pm.2023.131314. Epub 2023 Sep 20.
9
Maternal and fetal outcomes after bariatric surgeries.
Prz Menopauzalny. 2023 Sep;22(3):148-154. doi: 10.5114/pm.2023.131440. Epub 2023 Sep 25.
10
Vitamin D and vitamin D receptor polymorphism in Asian adolescents with primary dysmenorrhea.
BMC Womens Health. 2023 Aug 5;23(1):414. doi: 10.1186/s12905-023-02569-9.

本文引用的文献

1
Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.
PLoS Med. 2020 Jun 23;17(6):e1003132. doi: 10.1371/journal.pmed.1003132. eCollection 2020 Jun.
2
Elevated and diagnostic androgens of polycystic ovary syndrome.
Prz Menopauzalny. 2020 Mar;19(1):1-5. doi: 10.5114/pm.2020.95293. Epub 2020 Apr 27.
3
CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome.
Gynecol Endocrinol. 2021 Mar;37(3):230-234. doi: 10.1080/09513590.2020.1770724. Epub 2020 May 27.
4
Abdelazim and Sakiyeva endocrinopathy associated with polycystic ovary syndrome: Case reports.
J Family Med Prim Care. 2019 Sep 30;8(9):3039-3041. doi: 10.4103/jfmpc.jfmpc_646_19. eCollection 2019 Sep.
6
Polycystic ovarian syndrome: Environmental/occupational, lifestyle factors; an overview.
J Turk Ger Gynecol Assoc. 2019 Nov 28;20(4):255-263. doi: 10.4274/jtgga.galenos.2019.2018.0142. Epub 2019 Mar 1.
7
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Fertil Steril. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验